NanoString Technologies Inc.
530 Fairview Ave N
Seattle
Washington
98109
United States
Website: http://www.nanostring.com/
Email: info@nanostring.com
302 articles about NanoString Technologies Inc.
-
Bio-Techne and NanoString Partner to Co-Develop Integrated Workflow for RNA Spatial Profiling
3/28/2019
Integrated Workflow Combines NanoString's GeoMx DSP High-Plex RNA Assays and Bio-Techne's Highly Sensitive RNAscope Imaging Reagent Portfolio
-
NanoString To Release Second Quarter 2017 Financial Results And Host Conference Call On Tuesday, August 8, 2017
7/10/2017
-
NanoString Appoints J. Chad Brown As Senior Vice President Of Sales And Marketing
7/5/2017
-
NanoString Regroups After Pfizer Walks Away From R&D Pact
5/19/2017
-
NanoString Expands; New Biotech Silverback Therapeutics Sets Up Shop
7/14/2016
-
HalioDx And NanoString Enter Into Collaboration Agreement To Jointly Develop And Commercialize Novel Gene Expression Assays In Immuno-Oncology
4/11/2016
-
Adaptive Biotech, Juno, NanoString Continue Hiring Spree in Seattle
2/18/2016
-
NanoString Touts Collaborative Work in Immuno-Oncology at J.P. Morgan Conference
1/11/2016
-
NanoString Enters Into Collaboration Agreement With Medivation And Astellas To Develop Novel Companion Diagnostic Test
1/11/2016
-
NanoString Announces Eleven Prosigna/PAM50 Presentations At The 2015 CTRC-AACR San Antonio Breast Cancer Symposium
12/7/2015
-
NanoString To Present At Canaccord Genuity Medical Technology And Diagnostics Forum
11/6/2015
-
NanoString Expands 3D Biology Portfolio With The Commercial Launch Of Seven New Ncounter Pancancer Profiles To Deeply Probe Cancer Biology
11/5/2015
-
NanoString To Release Third Quarter 2015 Financial Results And Host Conference Call On Monday, November 2, 2015
10/13/2015
-
NanoString To Unveil Strategic Roadmap For Growth And Market Expansion
9/11/2015
-
NanoString Expands Immuno-Oncology Portfolio With Commercial Launch Of Innovative Ncounter RNA:Protein Pancancer Immune Profiling Panel
9/11/2015
-
NanoString Release: ESMO Clinical Practice Guidelines For Breast Cancer Recommend The Use Of Prosigna/PAM50 Assay For Determining Potential Benefit From Chemotherapy
9/9/2015
-
NanoString To Present At Upcoming Investor Conferences
8/27/2015
-
NanoString Receives Favorable Final Local Coverage Determination By Palmetto GBA For Its Prosigna Breast Cancer Assay
8/14/2015
-
Seattle Biotech NanoString's Revenue Up 20% as Company Shifts Focus to Cancer Diagnostics
8/5/2015
-
NanoString Releases Financial Results For Second Quarter Of 2015
8/5/2015